SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 323 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $56,191,000 | -67.7% | 758,413 | -75.7% | 2.23% | -65.4% |
| Q4 2017 | $173,999,000 | -1.6% | 3,127,225 | -19.7% | 6.44% | +50.3% |
| Q3 2017 | $176,755,000 | +102.5% | 3,896,731 | +50.5% | 4.28% | +154.9% |
| Q2 2017 | $87,297,000 | +55.9% | 2,589,681 | +36.9% | 1.68% | +16.5% |
| Q1 2017 | $55,981,000 | -34.1% | 1,891,218 | -38.9% | 1.44% | -11.8% |
| Q4 2016 | $84,944,000 | -31.3% | 3,096,756 | +53.8% | 1.63% | -35.2% |
| Q3 2016 | $123,619,000 | +588.2% | 2,013,000 | +118.7% | 2.52% | +553.6% |
| Q1 2016 | $17,963,000 | – | 920,243 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 290,000 | $44,066,000 | 9.14% |
| Avoro Capital Advisors LLC | 1,400,000 | $212,730,000 | 7.35% |
| NEXTHERA CAPITAL LP | 50,317 | $7,646,000 | 6.37% |
| Eventide Asset Management | 1,123,000 | $170,640,000 | 5.19% |
| RTW INVESTMENTS, LP | 604,236 | $91,814,000 | 4.90% |
| Casdin Capital, LLC | 335,000 | $50,903,250,000 | 4.76% |
| Copernicus Capital Management, LLC | 30,000 | $4,559,000 | 4.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 548,500 | $83,345,000 | 3.76% |
| Camber Capital Management LP | 500,000 | $75,975,000 | 3.54% |
| Dynamic Capital Management Ltd | 4,677 | $711,000 | 3.54% |